...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Atypical Femoral Fractures (AFF) from Bone Remodeling Agents in Patients with Cancer
【24h】

Atypical Femoral Fractures (AFF) from Bone Remodeling Agents in Patients with Cancer

机译:癌症患者骨改造剂的非典型股骨骨折(AFF)

获取原文
获取原文并翻译 | 示例
           

摘要

Anti-resorptive drugs like bisphosphonates (BP) and denosumab are widely used for prevention and treatment of skeletal diseases, such as osteoporosis and bone metastases and mainly work through the prevention of osteoclast-mediated bones resorption. BP can lead to atypical femoral fractures (AFF) that is a rare, easily misdiagnosed treatment-related complication with great impact on the quality of life of patients. We present a concise review of the literature on BP related AFF based on the cases of 3 breast cancer patients that reflect the diagnostic pitfall of this rare entity. In conclusion, breast cancer patients very often are exposed to BP use and are at risk of developing AFF.
机译:双膦酸盐(BP)和DeNOSumab等抗复苏药物广泛用于预防和治疗骨骼疾病,例如骨质疏松症和骨转移,主要通过预防破骨细胞介导的骨骼再吸收。 BP可以导致非典型股骨骨折(AFF),这是一种罕见,易于误诊的治疗相关的并发症,对患者的生活质量产生很大影响。 我们在基于3乳腺癌患者的情况下,对BP相关患者的文献提出了一个简明的审查,这些乳腺癌患者反映了这种罕见实体的诊断陷阱。 总之,乳腺癌患者经常暴露于BP使用,并且存在发育中的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号